Clinical Trial

Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study investigates the role of Lipoprotein(a) \[Lp(a)\] levels in predicting cardiovascular risk and adverse events in patients undergoing elective percutaneous coronary intervention (PCI).
Trial Details
NCT Number NCT07197242
Lead Sponsor Assiut University
Conditions PCI
Enrollment 156 participants
Start Date 2026-10-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-29